February 17, 2023
Via: Biopharma DiveThe Food and Drug Administration on Friday approved the first drug for a common and irreversible form of vision loss. Whether the medicine, developed by Apellis Pharmaceuticals, can safely help patients maintain their sight for longer isn’t yet clear, though, […]
July 11, 2024
July 11, 2024
July 19, 2024